anthracyclines

High-Sensitivity Troponin I: A Poor Predictor of Anthracycline-Induced Left Ventricular Dysfunction?

The Cardiac CARE trial reveals that high-sensitivity cardiac troponin I levels do not correlate with cumulative anthracycline dose and only weakly predict subsequent declines in left ventricular function, challenging existing risk-stratific

Sacubitril-Valsartan Prevents Anthracycline-Induced Myocardial Dysfunction: Results from the SARAH Trial